Easton Pharmaceuticals, Inc. EAPH Company Overview 

Stock Message Board http://investorshangout.com/search?q=EAPH&...mp;yt1=Go!

Easton Pharmaceuticals, Inc. EAPH Current Price and Quotes
0.0078
Previous Close
0.0075
Open
0.0085

Daily Range
0.009 - 0.0066
52wk Range
0.028 - 0.0014

Volume
13,829,305
Dividend
N/A

Average Vol (3m)
4,311,204
Yield
N/A

Easton Pharmaceuticals, Inc. EAPH
Company Information
425 University Ave
Suite 500
Toronto, ONT M5G1T6
Canada

Website: http://www.lamindustries.com
Phone: 416-619-0291
Email: info@lamindustries.com

Easton Pharmaceuticals, Inc. EAPH
Drug / OTC Research and Development

Easton Pharmaceuticals, Inc. EAPH
Financial Reportings and Disclosures
Reporting Status Alternative Reporting Standard
Deregistered a/o Jan 29, 2009
Audited Financials Unaudited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001071272
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 05, 1998
Incorporated In: WY, USA
Year of Inc. 1998
Employees 4 a/o Nov 27, 2012
Company Officers/Contacts
Walter Folinski CEO, President
John Adams CEO
Company Directors
Not Available
Company Notes
Formerly=LAM Industries Inc. until 3-2010
Formerly=L.A.M. Pharmaceutical Corp. until 4-2009
Service Providers
Auditor/Accountant
KBL, LLP
110 Wall Street
11th Floor
New York, NY, 10005
United States

Mehra & Associates
Palm Beach, FL, United States

Legal Counsel
William F. Doran
1717 East Bell Road
Phoenix, AZ, 85022
United States

Wilson & Oskam LLP
9110 Irvine Center Drive
Irvine, CA, 92618
United States

Investor Relations Firm
Not Available

Easton Pharmaceuticals, Inc. EAPH
EAPH Security Details
Share Structure
Market Value1 $996,942 a/o Aug 30, 2013
Shares Outstanding 127,813,017 a/o May 05, 2013
Float 62,811,618 a/o May 05, 2013
Authorized Shares 250,000,000 a/o Aug 02, 2013
Par Value  0.0001
Shareholders
Shareholders of Record 198 a/o May 05, 2013
Security Notes
Capital Change=shs decreased by 1 for 3000 split. Pay date=04/30/2009.
Short Selling Data
Short Interest 0 (-100%)
Jul 31, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Corporate Stock Transfer, Inc.

Easton Pharmaceuticals, Inc. EAPH Recent News


Aug 23, 2013 Easton Pharmaceuticals, Inc. Provides Update on Its Medical Marijuana Initiatives
Aug 20, 2013 OTC Daily Alert Stock Watch - Easton Pharmaceuticals (OTC: EAPH)
Aug 14, 2013 Easton Pharmaceuticals Announces It Has Ordered Ingredients towards Producing Final Test and Trial Samples of Its Re-Formulated Viorra and Other Recently Added Portfolio Products
Jul 9, 2013 Andrew Wellington s Ivy Family Office Network New York City Mid Year 2013 Forum
Jun 8, 2013 Easton Pharmaceuticals Announces Three New Additional Products and a Revision to Its Viorra Flagship Product Towards Resuming Its Latin American & South East Asia Initiatives
Jun 6, 2013 Easton Pharmaceuticals, Inc. Announces Its Entrance into the Medical Marijuana Sector
Jun 5, 2013 Easton Pharmaceuticals Announces Neil Mellor as Senior Consultant, Chief Operations Officer


Easton Pharmaceuticals, Inc. EAPH Financials
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development 68 6
Sales, General and Admin. 115 107
Non-Recurring Items - -
Other - -
Operating Income (183) (113)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (183) (113)
Interest Expense - -
Earnings Before Tax (183) (113)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (183) (113)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (183) (113)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (183) (113)